Nasogastric Versus Orogastric Route of Feeding in Preterm (<32 Weeks) Neonates
NCT ID: NCT03073993
Last Updated: 2017-03-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
160 participants
INTERVENTIONAL
2015-10-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The feeding tubes could be inserted by the nasogastric (NG) route or by the orogastric (OG) route. Both routes are used in different Neonatal Intensive Care Units (NICUs). Both methods are associated with different adverse events.
Since newborn infants are obligate nose breathers, nasogastric tube (NGT) can lead to partial nasal obstruction which might increase airway resistance and work of breathing although they are easy to secure to the face than orally placed tubes. Orogastric tubes (OGT), on the other hand, may not lead to the potential risk of increased work of breathing associated with NGT but are more frequently malpositioned and can loop inside the mouth. Also there is increased possibility of apnea and bradycardia due to vagal stimulation.
Despite so many years of continuing debate, the evidence of superiority of one method over another is not proven. Very few studies have tried to look into this matter and there are no consensus guidelines. This study is being conducted to compare the rate and type of adverse events in OG versus NG feeds in preterm neonates ≤ 32 weeks and postmenstrual age (PMA) ≤ 36 weeks.
Preterm neonates born at ≤ 32 weeks with PMA≤ 36 weeks who require feeding tube as a route for enteral feeding once they are out of respiratory support ( i.e ventilation or CPAP) are eligible candidates. Feeding tube insertion episode (FTIE) is defined as episode of insertion of OG or NG tube. FTIE will be randomized into NG or OG routes. Primary outcome is frequency of desaturation and bradycardia in each group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Positioning of EDI Catheter In Premature Infants
NCT05107713
Correct Gastric Tube Placement in Very Low Birth Weight Neonates
NCT04127773
Gastric Lipase Enhanced Nasogastric Tube Study in Neonates
NCT04271995
Preterm Newborn's Behavioral Responses During Feeding With Gastric Tube
NCT06634329
How to Optimize Enteral Feeding of the Full Enteral Feeding Preterm Infant
NCT06760832
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Each episode of insertion of either NGT or OGT will be labelled as Feeding tube insertion episode (FTIE) in the study. Total of 160 FTIE will be done in study period, 80 FTIEs in preterm neonates of \<30 weeks gestational age and 80 FTIE in preterm neonates of ≥30 weeks gestational age.
The method of FTIE (whether NG or OG) will be randomized into 2 groups by computer generated random sequence in blocks of 4 each. Stratification will be done as per Gestational age\< 30 weeks and ≥ 30 weeks. Randomization sequence will be stored in sealed opaque envelope which was kept with one person who will not involved in care of patients.
Tube insertion will be done by NICU nursing staff who are already trained and validated in putting tube. Length of NGT/OGT insertion will be calculated by distance from bridge of nose to ear lobe and then from ear lobe to midway between xiphisternum and umbilicus (NEMU method). Correct tube placement will be checked by first aspirating and then pushing in 2 ml air and listening by stethoscope.
Each FTIE will be followed till the tube required to be changed for any reason, or tube feeding terminated due to graduation to direct feeds by paladay or breast. If the tube is changed for any reason, the reinsertion of the tube will be taken as a fresh FTIE, and again followed as above.
To record adverse events, heart rate and oxygen saturations will be recorded in the monitor till the time tube remained in situ. Bradycardia is defined as Heart rate \< 100/min. Desaturation is defined as SpO2 \< 85%. Alarms on the multifunction monitors (Philips MP 20 Neonatal) will be set with lower limit of Heart rate as 100/min and lower limit of saturation as 85%. Episodes will be recorded on a proforma lying at bedside by the duty nurse on the data collection form which include demographic parameters notably name, age, sex, IP No, gestational age at birth in weeks+ days, PMA at enrollment (weeks+ days), method of feeding (OG or NG) along with clinical parameters in the form of desaturation episodes/hr and bradycardia episodes/hr.
If a tube remained in situ for more than 24 hours, a new sheet will be taken. Each time monitor give alarm for desaturation and/ or bradycardia, nurse will check the baby and monitor. If the waveform showed regular trend and probe is attached properly to baby, episode will be recorded. Since the duration of NG and OG tubes may vary, the number of episodes of bradycardia and /or desaturation episodes/hr will be compared.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nasogastric
Feeding tube insertion in nasogastric group
feeding tube insertion
Feeding tube was inserted in hemodynamically stable babies for purpose of feeding
Orogastric
Feeding tube insertion in orogastric group
feeding tube insertion
Feeding tube was inserted in hemodynamically stable babies for purpose of feeding
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
feeding tube insertion
Feeding tube was inserted in hemodynamically stable babies for purpose of feeding
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Severe congenital malformations, chromosomal abnormalities
* Baby requiring any respiratory support
* Sepsis, IVH, NEC or any illness explaining apneas
25 Weeks
32 Weeks
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Max Super Speciality Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
SYED AHMAD ZIA
DNB Resident in Pediatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Naveen P Gupta, MD, DNB
Role: STUDY_DIRECTOR
Consultant Neonatologist
References
Explore related publications, articles, or registry entries linked to this study.
Bohnhorst B, Cech K, Peter C, Doerdelmann M. Oral versus nasal route for placing feeding tubes: no effect on hypoxemia and bradycardia in infants with apnea of prematurity. Neonatology. 2010;98(2):143-9. doi: 10.1159/000279617. Epub 2010 Mar 16.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NGOG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.